DIN 00682020 — ERYTHRO-BASE 250 MG
ERYTHRO-BASE is a tablet of Erythromycin marketed by AA PHARMA INC. The full Erythromycin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00682020
- Brand name
- ERYTHRO-BASE
- Active ingredient
- Erythromycin
- Strength
- 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- AA PHARMA INC
- Health Canada status
- DORMANT
- Drug class
- Macrolide antibiotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Erythromycin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00545678 | ERYTHRO-S | 250 MG | TABLET | AA PHARMA INC | DORMANT |
| 00682276 | ERYTHROCIN I.V. | 1 G | POWDER FOR SOLUTION | AMDIPHARM LIMITED | MARKETED |
| 00682268 | ERYTHROCIN I.V. | 500 MG | POWDER FOR SOLUTION | AMDIPHARM LIMITED | MARKETED |
| 02141574 | ERYTHROMYCIN | 5 MG | OINTMENT | PHARMA STULLN INC. | MARKETED |
| 02326663 | ERYTHROMYCIN OPHTHALMIC OINTMENT USP | 5 MG | OINTMENT | STERI-MED PHARMA INC. | MARKETED |
| 00641324 | ODAN-ERYTHROMYCIN | 5 MG | OINTMENT | ODAN LABORATORIESLTD | DORMANT |
| 01912755 | PDP-ERYTHROMYCIN | 5 MG | OINTMENT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |